Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C*STEROID feasibility study before planned caesarean section
ACTRN12618002028280Phase 3Terminated
- Sponsor
- The University of Auckland
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN) and Neonatal hypoglycemia comparing Betamethasone with Placebo (2 arms). Primary endpoint: Trial recruitment rate. Started Jun 2019; status: terminated.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)transient tachypnea of the newborn (TTN)Neonatal hypoglycemia
Beyond the preview
Go deeper on ACTRN12618002028280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618002028280.